Cancer Immunotherapy: Combinations


By 2025, most patients with cancer will receive immunotherapy as part of their treatment regimen. This symposium will cover the most critical topics integral to this vision: How can we integrate, sequence or combine immunotherapy with standard-of-care cytotoxic therapy, radiotherapy and targeted therapies? Which preclinical models are best predictive of combination approaches? How do we combine immune agonists as well as molecules inhibiting immune-suppressive pathways with checkpoint inhibitors? What are the rational combinations for cancer vaccines and viro-therapy? Which combinatorial approaches could prevent or treat adaptive mechanisms of resistance? Most immunotherapies are being developed in isolation, or being tested as single agents in preclinical models or in clinical studies. This conference helps to address the gaps in knowledge of how and when to combine therapies, and how to integrate immunotherapy into current standard-of-care or novel targeted therapy approaches – both preclinical and clinical. 

Overall, the objectives of this meeting are to: 

  1. Elucidate rational combinations for immunotherapy; 
  2. Discuss preclinical and other models to inform combinatorial approaches; 
  3. Understand the relevance for biomarker approaches; and 
  4. Provide insights into the latest preclinical and clinical data for immunotherapy combinations.

To view the program of this conference, visit  www.keystonesymposia.org/18C5


 

About Keystone Symposia

Keystone Symposia convenes dynamic, open, peer-reviewed conferences on the exciting new frontiers of life science. Whether you are a geneticist, an immunologist or virtually any other type of life science investigator, and whether you are from academia, industry or the government/nonprofit sector, we think you will find the experience of attending a Keystone Symposia meeting valuable and memorable.

Keystone Symposia on Molecular and Cellular Biology is a 501(c)(3) nonprofit organization with a 45-year history of convening open, peer-reviewed conferences that connect the scientific community and accelerate life science discovery.

Learn more about our Conference Series